Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Viagrande

4 clinical trials in Viagrande, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Viagrande at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Viagrande

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Fondazione IRCCS Istituto Nazionale Dei Tumori
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Viagrande

What the registry says about research in the country

01 Breast Cancer Research

Investigation focusing on node-positive, estrogen receptor-positive, HER2-negative early breast cancer treatments, evaluating novel endocrine therapy approaches for patients with high recurrence risk.

  • Endocrine Therapy Comparison
  • Recurrence Risk Assessment
  • Hormone Receptor Studies

This research aims to improve treatment outcomes for breast cancer patients through targeted therapeutic interventions.

02 Colorectal Cancer Studies

Research examining treatment strategies for metastatic colorectal cancer, comparing the effectiveness of different biological therapies combined with chemotherapy.

  • First-line Treatment Optimization
  • Biomarker Analysis
  • Combination Therapy Assessment

These trials focus on personalizing treatment approaches based on specific genetic mutations.

03 Neuroendocrine Tumor Research

Comprehensive studies on gastroenteropancreatic and thoracic neuroendocrine tumors, including innovative combination therapies and targeted treatment approaches.

  • Novel Drug Combinations
  • Biomarker Identification
  • Treatment Response Assessment

Investigation of new therapeutic strategies for rare and complex neuroendocrine cancers.

04 Lung Cancer Therapeutics

Innovative research focusing on pulmonary large-cell neuroendocrine carcinoma, exploring immunotherapy combinations with traditional chemotherapy approaches.

  • Immunotherapy Integration
  • Treatment-Naïve Patient Studies
  • Combination Therapy Efficacy

These trials aim to establish more effective treatment protocols for aggressive lung cancers.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.